The Cochrane Editorial Unit has announced the 10 successful titles from the second Cochrane Review Support Programme (CRSP) funding round.

1. Delayed antibiotics for respiratory infections (Acute Respiratory Infections Group)
2. Bisphosphonates and other bone agents for breast cancer (Breast Cancer Group)
3. Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises (Common Mental Disorders Group)
4. Drug eluting stents versus bare metal stents for acute coronary syndrome (Heart Group)
5. Withdrawal of antihypertensive drugs in older people (Hypertension Group)
6. Pharmacotherapy for hypertension in adults aged 18 to 59 years (Hypertension Group)
7. Interventions for preventing obesity in children (Public Health Group)
8. Taxation of sugar-sweetened beverages for reducing their consumption and preventing obesity or other adverse health outcomes (Public Health Group)
9. Interventions for treating depression after stroke (Stroke Group)
10. Interventions to prevent occupational noise-induced hearing loss (Work Group)

These titles were selected from a pool of 23 applications received from 16 Cochrane Review Groups. For complete details of the selection panel and process, please see the full announcement on cochrane.org.

The next funding round will open in September 2016 and will be advertised via the usual Cochrane communication channels.